Dakota was originally established as a limited company on 1999, with Wu Qingjun contributing 300,000 yuan and He Junfeng contributing 200,000 yuan respectively. In 20 16, Dakota was changed into a joint stock company as a whole, that is, at this time (the daughter) and He appeared in the list of shareholders.
Da Kewei said that He Zhenglong is eligible to become a shareholder of the company, and his shareholder rights can be exercised by his legal representative He Junfeng.
Lou Xiaoyun, a lawyer of Zhejiang Xinzhuan Law Firm, further explained that although this situation is not common in practice, the Company Law has no restrictions on whether minors can become shareholders of the company. Therefore, minors can become shareholders of the company, and their shareholder rights can be exercised by legal agents.
According to the prospectus, Dakota is a professional provider focusing on life science research services and pathological diagnosis.
In the field of life science research services, Dako is mainly engaged in the agent sales of scientific research reagents and instruments, as well as the independent research and development, production and sales of some scientific research reagents.
In the field of pathological diagnosis, Dakota is mainly engaged in the research and development, production and sales of pathological diagnosis equipment and reagents.
Brief introduction of Beijing Dakewei Biotechnology Co., Ltd.;
Beijing Dakewei Biotechnology Co., Ltd. was established at No.065438+on October 30th, 2008, with its registered address at Room 60 1-606, Floor 6, Building 5, No.38, LAM Raymond Second Road, Haidian District, Beijing, and its legal representative is Wu Qingjun.
The business scope includes general projects: technical service, technical development, technical consultation, technical exchange, technology transfer and technology popularization; Import and export of goods; Technology import and export; Import and export agent; Sales of first-class medical devices; Sales of second-class medical devices; Instrument sales; Sales of chemical products (excluding licensed chemical products).
Medical research and experimental development; Non-residential real estate leasing. (except for projects that need to be approved according to law, business activities can be independently carried out according to law with business licenses) Licensed projects: Category II value-added telecommunications services; Internet information service.
The third kind of medical device management. (Projects that must be approved according to law can only be operated after being approved by the relevant departments. The specific business projects shall be subject to the approval documents or licenses of the relevant departments.) (Do not engage in project business activities prohibited or restricted by the national and municipal industrial policies. ) Beijing Dakota Biotechnology Co., Ltd. invested in 3 companies and 8 branches. ..